Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 11:49 am Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 984,075 7.600% | -25,015 (-2.48%) | Filing History |
| 2024-01-22 2:04 pm Sale | 2023-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 222,594 1.710% | -729,432 (-76.62%) | Filing History |
| 2023-07-07 4:35 pm Sale | 2023-06-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,009,090 7.700% | -863,811 (-46.12%) | Filing History |
| 2023-02-14 4:34 pm Purchase | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Tarriff Scott | 2,533,457 18.060% | 113,483 (+4.69%) | Filing History |
| 2023-02-13 09:26 am Sale | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,229,872 9.400% | -298,280 (-19.52%) | Filing History |
| 2023-02-09 11:16 am Purchase | 2022-12-30 | 13G | Eagle Pharmaceuticals, Inc. EGRX | The Vanguard Group | 763,807 5.870% | 3,339 (+0.44%) | Filing History |
| 2023-02-03 4:08 pm Purchase | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 952,026 7.310% | 243,802 (+34.42%) | Filing History |
| 2023-01-26 08:52 am Unchanged | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,872,901 14.400% | 0 (Unchanged) | Filing History |
| 2023-01-20 3:00 pm Sale | 2022-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,872,901 14.400% | -95,915 (-4.87%) | Filing History |
| 2022-02-14 4:13 pm Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Park West Asset Management LLC | 0 0.000% | -791,600 (Position Closed) | Filing History |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Tarriff Scott | 2,419,974 17.610% | 99,355 (+4.28%) | Filing History |
| 2022-02-11 09:41 am Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | STATE STREET CORP STT | 708,224 5.480% | -105,877 (-13.01%) | Filing History |
| 2022-02-10 6:01 pm Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,528,152 11.800% | -165,921 (-9.79%) | Filing History |
| 2022-02-09 3:43 pm Sale | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | The Vanguard Group | 760,468 5.890% | -4,467 (-0.58%) | Filing History |
| 2022-01-27 11:00 am Unchanged | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,968,816 15.200% | 0 (Unchanged) | Filing History |
| 2022-01-25 3:03 pm Purchase | 2021-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | BlackRock Inc. BLK | 1,968,816 15.200% | 27,800 (+1.43%) | Filing History |
| 2021-02-16 5:20 pm Purchase | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Tarriff Scott | 2,320,619 16.660% | 181,403 (+8.48%) | Filing History |
| 2021-02-16 4:34 pm Sale | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Park West Asset Management LLC | 791,600 6.100% | -380,280 (-32.45%) | Filing History |
| 2021-02-16 3:07 pm Sale | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | Armistice Capital, LLC | 364,000 2.800% | -392,000 (-51.85%) | Filing History |
| 2021-02-11 4:39 pm Sale | 2020-12-31 | 13G | Eagle Pharmaceuticals, Inc. EGRX | JANUS HENDERSON GROUP PLC JHG | 1,694,073 13.000% | -105,636 (-5.87%) | Filing History |